Anna Haas is Chief Commercial Officer at Oviva, Europe’s leading provider of reimbursed digital therapies for obesity and related chronic conditions. She is responsible for Oviva’s country operations in the UK, Germany, and Switzerland, driving the company’s mission to make high-quality chronic care accessible at scale. Founded in 2014, Oviva combines behavioral science, clinical expertise, and modern technology to deliver effective, human-centred digital care. Its evidence-based approach has already supported more than one million people across Europe. At the forefront of digital health innovation, Oviva increasingly integrates AI to personalise treatment, enhance patient engagement, and strengthen preventive care within healthcare systems.